semaglutide fda news 🎉Exciting that is now approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% fda compounding semaglutide warning letter

Bodell, L

H.MacConellL

Slow withdrawal can cause a small amount of Lipo Lab stock solution (approximately 0.01 ml) remaining on the inner wall of the to be smeared on the penetrated dermal wound, causing inflammatory erythema that is difficult to subside within 14 days after surgery

The British Association of Dermatologists is now on the alert for patients with warning signs of unusual orange tans and disordered moles

AST is one of the two major liver enzymes and is crucial for amino acid metabolism

While it's safe to stop semaglutide abruptly, many experts recommend a gradual taper to reduce a sudden increase in appetite and weight regain